FilingIndex
DEF 14AThe Ballot

Theriva Biologics, Inc. files DEF 14A

Filed Aug 14, 2023 · 2y ago · Accession 0001104659-23-091498

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
TOVX
CIK
894158
Form type
DEF 14A
Filing date
Aug 14, 2023
Report date
Oct 2, 2023
Document
tm2323689d1_def14a.htm
Size
739 KB